UDCA (Ursodeoxycholic acid) Clinical Trials

4 actively recruiting trials

▲ +1 trial since August 2026

Pipeline

Phase 2: 2Phase 3: 1

Top Sponsors

Xijing Hospital of Digestive Diseases1
University Hospital, Montpellier1
Phenomen Pharma1
Jinling Hospital, China1

Indications

Liver Disease2
Cancer2
Immune-Mediated Cholestasis1
Fatty Liver, Alcoholic1
Nonalcoholic Fatty Liver (NAFL)1

Other4 trials

Comparing UDCA and Corticosteroids in Immunotherapy Induced Cholestatic Hepatitis

Phase 2

FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy

Phase 3

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

N/A

Perioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.